Survival in the Intensive Care Unit: A Prognosis Patient with Rheumatoid Diseases
-
Soheila Sadeghi
,
Mahmoud Dehghani-Ghorbi
,
Amir Behnam Kharazmi
,
Seyed Amir Sheikholeslami
,
Parisa Delkash
Abstract
Background: Rheumatic diseases can lead to increased mortality and decreased quality of life. Therefore, we conducted this study to determine the clinical characteristics of patients with rheumatic diseases hospitalized in the ICU.
Methods: In this study, which was conducted in Tehran province, patients who were diagnosed with underlying rheumatic diseases and were admitted to the ICI department were included in the study. Thus, the study encompassed 120 patients diagnosed with rheumatic diseases. In this study, the researchers extracted the list of hospitalized patients by referring to the ICU department. Then, a history was taken from the patients, and if they were suffering from underlying rheumatic disease according to the history taken (from the patient or the patient's companion), they were included in the study. The tools used included a demographic profile form and a patient clinical information checklist. The data obtained from this study were analyzed using SPSS software version 16.
Results: The results showed there was a significant relationship between gender, history of hospitalization, smoking, pressure ulcer, and age with the mortality of ICI patients (P value < 0.05). Also, a higher mortality rate was reported in all patients who had at least one type of underlying disease (P value < 0.05). Therefore, the ICU hospitalized the older patients for longer periods of time.
Conclusion: Variables such as age, sex, and underlying diseases were effective in the clinical condition of patients with RA. For this reason, it is necessary to pay attention to this issue in providing clinical care.
[1] Mohammadi HR, Erfani A, Sadeghi S, Komlakh K, Otaghi M, Vasig A. Investigating factors affecting mortality due to spinal cord trauma in patients admitted to the intensive care unit. Bull Emerg Trauma. 2024; 12(3):136-41
[2] Salmani F, Moghimian M, Jouzi M. The effect of planned presence of the family at the time of weaning on the length of weaning from mechanical ventilation in patients with brain injury admitted to intensive care units. BMC Nurs. 2022; 21(1):328.
[3] Moiseev S, Avdeev S, Brovko M, Yavorovskiy A, Novikov PI, Umbetova K, et al. Rheumatic diseases in intensive care unit patients with COVID-19. Ann Rheum Dis. 2021; 80(2):e16-e.
[4] Mustafa M, Gladston Chelliah E, Hughes M. Patients with systemic rheumatic diseases admitted to the intensive care unit: what the rheumatologist needs to know. Rheumatology (Oxford). 2018; 38:1163-8.
[5] Radhakrishna SM, Reiff AO, Marzan KA, Azen C, Khemani RG, Rubin S, et al. Pediatric rheumatic disease in the intensive care unit: lessons learned from 15 years of experience in a tertiary care pediatric hospital. Pediatr Crit Care Med. 2012; 13(3):e181-e6.
[6] Toledano E, Candelas G, Rosales Z, Prada CM, León L, Abásolo L, et al. A meta-analysis of mortality in rheumatic diseases. Reumatol Clin. 2012; 8(6):334-41.
[7] Bournia V-K, Fragoulis GE, Mitrou P, Mathioudakis K, Tsolakidis A, Konstantonis G, et al. All-cause mortality in systemic rheumatic diseases under treatment compared with the general population, 2015–2019. RMD Open. 2021; 7(3):e001694.
[8] Dadonienė J, Charukevič G, Jasionytė G, Staškuvienė K, Miltinienė D. Mortality in inflammatory rheumatic diseases: Lithuanian national registry data and systematic review. Int J Environ Res Public Health. 2021; 18(23):12338.
[9] Quintana G, Coral-Alvarado P. Economic impact of rheumatic diseases. Challenges in Rheumatology: IntechOpen; 2011.
[10] Chaleshgar Kordasiabi M, Akhlaghi M, Askarishahi M, Sabzmakan L, Abbasi Shavazi M. Quality of life and related factors in rheumatoid arthritis patients. J Health Res Community. 2016; 2(3):1-11.
[11] Nurmohamed MT, Heslinga M, Kitas GD. Cardiovascular comorbidity in rheumatic diseases. Nat Rev Rheumatol. 2015; 11(12):693-704.
[12] Beil M, Sviri S, de la Guardia V, Stav I, Ben-Chetrit E, van Heerden P. Prognosis of patients with rheumatic diseases admitted to intensive care. Anaesth Intensive Care. 2017; 45(1):67-72.
[13] Li W-J, Wang X-L, Chu Y-R, Wang J-X, Xu S-Q. Association of sarcopenia and vitamin D deficiency with glucocorticoid-induced osteoporosis in Chinese patients with rheumatoid arthritis. Clin Rheumatol. 2024; 43(1):15-22.
[14] Sagtaganov Z, Bekaryssova D. Complex rehabilitation of patients with rheumatoid arthritis. Rheumatology (Oxford). 2024; 44(9):1789-93.
[15] Finckh A, Gilbert B, Hodkinson B, Bae S-C, Thomas R, Deane KD, et al. Global epidemiology of rheumatoid arthritis. Nat Rev Rheumatol. 2022; 18(10):591-602.
[16] van der Woude D, van der Helm-van AH. Update on the epidemiology, risk factors, and disease outcomes of rheumatoid arthritis. Best Pract Res Clin Rheumatol. 2018; 32(2):174-87.
[17] Almutairi KB, Nossent JC, Preen DB, Keen HI, Inderjeeth CA. The prevalence of rheumatoid arthritis: a systematic review of population-based studies. J Rheumatol. 2021; 48(5):669-76.
[18] Alimoradian A, Garshasbi M, Asafari M, Golitaleb M, Mansouri Tabar R, Mortaji Khiabani S, et al. Effect of silymarin on hepatic complications caused by methotrexate and its analgesic effects in patients with rheumatoid arthritis. Sci J Kurdistan Univ Med Sci. 2023; 28(4):95-109.
[19] Mustafa M, Gladston Chelliah E, Hughes M. Patients with systemic rheumatic diseases admitted to the intensive care unit: what the rheumatologist needs to know. Rheumatology Int. 2018; 38(7):1163-8.
[20] Javadi F, Ahmadzadeh A, Eghtesadi S, Aryaeian N, Zabihiyeganeh M, Rahimi Foroushani A, et al. The effect of quercetin on inflammatory factors and clinical symptoms in women with rheumatoid arthritis: a double-blind, randomized controlled trial. J Am Coll Nutr. 2017; 36(1):9-15.
[21] Petrovská N, Prajzlerová K, Vencovský J, Šenolt L, Filková M. The pre-clinical phase of rheumatoid arthritis: from risk factors to prevention of arthritis. Autoimmun Rev. 2021; 20(5):102797.
[22] AzadP FM. Experience of living with systemic lupus erythematosus: a phenomenological study. Med Surg Nurs J. 2015; 4(1):1-9.
[23] Wind M, Fierro JJ, Bloemenkamp KW, de Leeuw K, Lely AT, Limper M, et al. Pregnancy outcome predictors in systemic lupus erythematosus: a systematic review and meta-analysis. Lancet Rheumatol. 2024.
[24] Williamson L, Hao Y, Basnayake C, Oon S, Nikpour M, editors. Systematic review of treatments for the gastrointestinal manifestations of systemic lupus erythematosus. Semin Arthritis Rheum. 2024. Elsevier.
[25] Rütter LA, Rütter S, Winkler M, Keyßer G. Outcome of intensive medical care for inflammatory rheumatic diseases. Z Rheumatol. 2017; 76(9):780-7.
[26] Krasselt M, Baerwald C, Petros S, Seifert O. Mortality of sepsis in patients with rheumatoid arthritis: a single-center retrospective analysis and comparison with a control group. J Intensive Care Med. 2021; 36(7):766-74.
[27] Pope JE, Choy EH, editors. C-reactive protein and implications in rheumatoid arthritis and associated comorbidities. Semin Arthritis Rheum. 2021. Elsevier.
[28] Esalatmanesh K, Soleimani Z, Azadchehr M, Saghazadeh A, Esalatmanesh R. Evaluation of factors affecting the prognosis of COVID-19 in patients with rheumatic inflammatory diseases: A retrospective multi-centric cohort study. Feyz Med Sci J. 2021; 25(5):1244-54.
[29] Erfani A, Aghamiri SH, Karimi R. Investigating the role of hyperdensity signal length in the middle cerebral artery on the degree of disability of arterial ischemic stroke patients. Arch Neurosci. 2024; 11(4):e150888.
[30] Mohammadi HR, Asadoola Y, Erfani A, Ghoreishi Amin N, Karimiyarandi H, Sadeghi S, et al. Effectiveness of pulse intravenous infusion of methylprednisolone on pain in patients with lumbar disc herniation: a randomized controlled trial. Anesth Pain Med. 2024; 14(4):e149442.
[31] Abdi Z, Roozegar MA, Beigi S, Khorshidi A, Azizian M, Beigi Z. Using simvastatin mouthwash (0.6%, 1.2% and 1.8%) on the improvement of clinical parameters in patients with chronic periodontitis. Research Journal of Pharmacy and Technology. 2020;13(2):862-6.
[32] Roozegar MA, Nourmohammadi H, Havasian M, Seidkhani H, Jamdar S. Evaluation of Oral and Dental complications caused by Cyclophosphamide in patients with breast cancer in the Shahid-Mostafa Hospital, Ilam, 2019. Research Journal of Pharmacy and Technology. 2022;15(12):5517-20.
[33] Esmaeilikia M, Gholami-Parizad E, Ghazanfari Z, Abedzadeh M-S, Roozegar M-A. Investigation of oral health status (DMFT-index) among 3–6 years old children in Ilam (Western Iran), 2015. Res J Pharm Tech. 2020; 13(4):1878-82.
[34] Brünnler T, Susewind M, Hoffmann U, Rockmann F, Ehrenstein B, Fleck M. Outcomes and prognostic factors in patients with rheumatologic diseases admitted to the ICU. Intern Med. 2015; 54(16):1981-7.
[35] Larcher R, de Chambrun MP, Garnier F, Rubenstein E, Carr J, Charbit J, et al. One-year outcome of critically ill patients with systemic rheumatic disease: a multicenter cohort study. Chest. 2020; 158(3):1017-26.
[36] Cavallasca JA, del Rosario Maliandi M, Sarquis S, Nishishinya MB, Schvartz A, Capdevila A, et al. Outcome of patients with systemic rheumatic diseases admitted to a medical intensive care unit. J Clin Rheumatol. 2010; 16(8):400-2.
[37] Hinkle JL, Cheever KH. Brunner and Suddarth’s textbook of medical-surgical nursing. 14th ed. Wolters Kluwer India Pvt Ltd; 2018.
[38] Karimipour F, Fayazi S, Mowla K, Latifi SM. Effect of acupressure on severity of pain in rheumatoid arthritis patients. Jundishapur Sci Med J. 2012; 11(3):269-75.
[2] Salmani F, Moghimian M, Jouzi M. The effect of planned presence of the family at the time of weaning on the length of weaning from mechanical ventilation in patients with brain injury admitted to intensive care units. BMC Nurs. 2022; 21(1):328.
[3] Moiseev S, Avdeev S, Brovko M, Yavorovskiy A, Novikov PI, Umbetova K, et al. Rheumatic diseases in intensive care unit patients with COVID-19. Ann Rheum Dis. 2021; 80(2):e16-e.
[4] Mustafa M, Gladston Chelliah E, Hughes M. Patients with systemic rheumatic diseases admitted to the intensive care unit: what the rheumatologist needs to know. Rheumatology (Oxford). 2018; 38:1163-8.
[5] Radhakrishna SM, Reiff AO, Marzan KA, Azen C, Khemani RG, Rubin S, et al. Pediatric rheumatic disease in the intensive care unit: lessons learned from 15 years of experience in a tertiary care pediatric hospital. Pediatr Crit Care Med. 2012; 13(3):e181-e6.
[6] Toledano E, Candelas G, Rosales Z, Prada CM, León L, Abásolo L, et al. A meta-analysis of mortality in rheumatic diseases. Reumatol Clin. 2012; 8(6):334-41.
[7] Bournia V-K, Fragoulis GE, Mitrou P, Mathioudakis K, Tsolakidis A, Konstantonis G, et al. All-cause mortality in systemic rheumatic diseases under treatment compared with the general population, 2015–2019. RMD Open. 2021; 7(3):e001694.
[8] Dadonienė J, Charukevič G, Jasionytė G, Staškuvienė K, Miltinienė D. Mortality in inflammatory rheumatic diseases: Lithuanian national registry data and systematic review. Int J Environ Res Public Health. 2021; 18(23):12338.
[9] Quintana G, Coral-Alvarado P. Economic impact of rheumatic diseases. Challenges in Rheumatology: IntechOpen; 2011.
[10] Chaleshgar Kordasiabi M, Akhlaghi M, Askarishahi M, Sabzmakan L, Abbasi Shavazi M. Quality of life and related factors in rheumatoid arthritis patients. J Health Res Community. 2016; 2(3):1-11.
[11] Nurmohamed MT, Heslinga M, Kitas GD. Cardiovascular comorbidity in rheumatic diseases. Nat Rev Rheumatol. 2015; 11(12):693-704.
[12] Beil M, Sviri S, de la Guardia V, Stav I, Ben-Chetrit E, van Heerden P. Prognosis of patients with rheumatic diseases admitted to intensive care. Anaesth Intensive Care. 2017; 45(1):67-72.
[13] Li W-J, Wang X-L, Chu Y-R, Wang J-X, Xu S-Q. Association of sarcopenia and vitamin D deficiency with glucocorticoid-induced osteoporosis in Chinese patients with rheumatoid arthritis. Clin Rheumatol. 2024; 43(1):15-22.
[14] Sagtaganov Z, Bekaryssova D. Complex rehabilitation of patients with rheumatoid arthritis. Rheumatology (Oxford). 2024; 44(9):1789-93.
[15] Finckh A, Gilbert B, Hodkinson B, Bae S-C, Thomas R, Deane KD, et al. Global epidemiology of rheumatoid arthritis. Nat Rev Rheumatol. 2022; 18(10):591-602.
[16] van der Woude D, van der Helm-van AH. Update on the epidemiology, risk factors, and disease outcomes of rheumatoid arthritis. Best Pract Res Clin Rheumatol. 2018; 32(2):174-87.
[17] Almutairi KB, Nossent JC, Preen DB, Keen HI, Inderjeeth CA. The prevalence of rheumatoid arthritis: a systematic review of population-based studies. J Rheumatol. 2021; 48(5):669-76.
[18] Alimoradian A, Garshasbi M, Asafari M, Golitaleb M, Mansouri Tabar R, Mortaji Khiabani S, et al. Effect of silymarin on hepatic complications caused by methotrexate and its analgesic effects in patients with rheumatoid arthritis. Sci J Kurdistan Univ Med Sci. 2023; 28(4):95-109.
[19] Mustafa M, Gladston Chelliah E, Hughes M. Patients with systemic rheumatic diseases admitted to the intensive care unit: what the rheumatologist needs to know. Rheumatology Int. 2018; 38(7):1163-8.
[20] Javadi F, Ahmadzadeh A, Eghtesadi S, Aryaeian N, Zabihiyeganeh M, Rahimi Foroushani A, et al. The effect of quercetin on inflammatory factors and clinical symptoms in women with rheumatoid arthritis: a double-blind, randomized controlled trial. J Am Coll Nutr. 2017; 36(1):9-15.
[21] Petrovská N, Prajzlerová K, Vencovský J, Šenolt L, Filková M. The pre-clinical phase of rheumatoid arthritis: from risk factors to prevention of arthritis. Autoimmun Rev. 2021; 20(5):102797.
[22] AzadP FM. Experience of living with systemic lupus erythematosus: a phenomenological study. Med Surg Nurs J. 2015; 4(1):1-9.
[23] Wind M, Fierro JJ, Bloemenkamp KW, de Leeuw K, Lely AT, Limper M, et al. Pregnancy outcome predictors in systemic lupus erythematosus: a systematic review and meta-analysis. Lancet Rheumatol. 2024.
[24] Williamson L, Hao Y, Basnayake C, Oon S, Nikpour M, editors. Systematic review of treatments for the gastrointestinal manifestations of systemic lupus erythematosus. Semin Arthritis Rheum. 2024. Elsevier.
[25] Rütter LA, Rütter S, Winkler M, Keyßer G. Outcome of intensive medical care for inflammatory rheumatic diseases. Z Rheumatol. 2017; 76(9):780-7.
[26] Krasselt M, Baerwald C, Petros S, Seifert O. Mortality of sepsis in patients with rheumatoid arthritis: a single-center retrospective analysis and comparison with a control group. J Intensive Care Med. 2021; 36(7):766-74.
[27] Pope JE, Choy EH, editors. C-reactive protein and implications in rheumatoid arthritis and associated comorbidities. Semin Arthritis Rheum. 2021. Elsevier.
[28] Esalatmanesh K, Soleimani Z, Azadchehr M, Saghazadeh A, Esalatmanesh R. Evaluation of factors affecting the prognosis of COVID-19 in patients with rheumatic inflammatory diseases: A retrospective multi-centric cohort study. Feyz Med Sci J. 2021; 25(5):1244-54.
[29] Erfani A, Aghamiri SH, Karimi R. Investigating the role of hyperdensity signal length in the middle cerebral artery on the degree of disability of arterial ischemic stroke patients. Arch Neurosci. 2024; 11(4):e150888.
[30] Mohammadi HR, Asadoola Y, Erfani A, Ghoreishi Amin N, Karimiyarandi H, Sadeghi S, et al. Effectiveness of pulse intravenous infusion of methylprednisolone on pain in patients with lumbar disc herniation: a randomized controlled trial. Anesth Pain Med. 2024; 14(4):e149442.
[31] Abdi Z, Roozegar MA, Beigi S, Khorshidi A, Azizian M, Beigi Z. Using simvastatin mouthwash (0.6%, 1.2% and 1.8%) on the improvement of clinical parameters in patients with chronic periodontitis. Research Journal of Pharmacy and Technology. 2020;13(2):862-6.
[32] Roozegar MA, Nourmohammadi H, Havasian M, Seidkhani H, Jamdar S. Evaluation of Oral and Dental complications caused by Cyclophosphamide in patients with breast cancer in the Shahid-Mostafa Hospital, Ilam, 2019. Research Journal of Pharmacy and Technology. 2022;15(12):5517-20.
[33] Esmaeilikia M, Gholami-Parizad E, Ghazanfari Z, Abedzadeh M-S, Roozegar M-A. Investigation of oral health status (DMFT-index) among 3–6 years old children in Ilam (Western Iran), 2015. Res J Pharm Tech. 2020; 13(4):1878-82.
[34] Brünnler T, Susewind M, Hoffmann U, Rockmann F, Ehrenstein B, Fleck M. Outcomes and prognostic factors in patients with rheumatologic diseases admitted to the ICU. Intern Med. 2015; 54(16):1981-7.
[35] Larcher R, de Chambrun MP, Garnier F, Rubenstein E, Carr J, Charbit J, et al. One-year outcome of critically ill patients with systemic rheumatic disease: a multicenter cohort study. Chest. 2020; 158(3):1017-26.
[36] Cavallasca JA, del Rosario Maliandi M, Sarquis S, Nishishinya MB, Schvartz A, Capdevila A, et al. Outcome of patients with systemic rheumatic diseases admitted to a medical intensive care unit. J Clin Rheumatol. 2010; 16(8):400-2.
[37] Hinkle JL, Cheever KH. Brunner and Suddarth’s textbook of medical-surgical nursing. 14th ed. Wolters Kluwer India Pvt Ltd; 2018.
[38] Karimipour F, Fayazi S, Mowla K, Latifi SM. Effect of acupressure on severity of pain in rheumatoid arthritis patients. Jundishapur Sci Med J. 2012; 11(3):269-75.
| Files | ||
| Issue | Article in Press |
|
| Section | Research Article(s) | |
| Keywords | ||
| Intensive Care Unit rheumatoid Diseases Survival | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
How to Cite
1.
Sadeghi S, Dehghani-Ghorbi M, Kharazmi AB, Sheikholeslami SA, Delkash P. Survival in the Intensive Care Unit: A Prognosis Patient with Rheumatoid Diseases. Arch Anesth & Crit Care. 2025;.
